Standard BioTools stock, SomaLogic stock fall on merger news

Photo of author

By Ronald Tech

Standard BioTools and SomaLogic Merger Impact on Stock Prices

Stocks Tumble After Shareholder Approval of Standard BioTools and SomaLogic Merger

Documents about mergers and acquisitions m&a with a pen.


  • Standard BioTools (NASDAQ:LAB) and SomaLogic’s (NASDAQ:SLGC) shares stumbled on Friday following approval from both lab tool makers’ shareholders for their proposed merger.
  • Having received investors’ consent, the merger is slated to be finalized on January 5, 2024, subject to meeting other closing conditions, as stated by both companies after holding separate special meetings concerning the deal.

See also  Exploring Psilocybin's Potential In New Trials To Treat IBS And Fibromyalgia Unveiling Psilocybin's Therapeutic Prospects